{"id":"NCT02915159","sponsor":"Bristol-Myers Squibb","briefTitle":"A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome","officialTitle":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Primary Sjögrens Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-06","primaryCompletion":"2018-08-07","completion":"2019-07-23","firstPosted":"2016-09-26","resultsPosted":"2020-01-02","lastUpdate":"2020-08-10"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sjogrens Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Abatacept","otherNames":["Orencia","Bristol-Myers Squibb (BMS)-188667"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Abatacept","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.","primaryOutcome":{"measure":"Change From Baseline in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI)","timeFrame":"Day 169","effectByArm":[{"arm":"Abatacept - Double Blind Treatment Period","deltaMin":-3.2,"sd":null},{"arm":"Placebo - Double Blind Treatment Period","deltaMin":-3.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.4421"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":71,"countries":["United States","Argentina","Australia","Brazil","Czechia","France","Germany","Italy","Japan","Mexico","Puerto Rico","South Korea","Sweden"]},"refs":{"pmids":[],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/investigator-inquiry-form.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":92},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Urinary tract infection","Diarrhoea"]}}